{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:46:04Z","timestamp":1740123964164,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Norwegian health association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s11136-015-1186-1","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T06:26:47Z","timestamp":1448346407000},"page":"1703-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Validity of standard gamble utilities in patients referred for aortic valve replacement"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-7693","authenticated-orcid":false,"given":"Amjad I.","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Garratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Otto","family":"Beitnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell I.","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"17","key":"1186_CR1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon, M. B., et al. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597\u20131607.","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"1186_CR2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/CIRCULATIONAHA.111.040022","volume":"124","author":"MR Reynolds","year":"2011","unstructured":"Reynolds, M. R., et al. (2011). Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation, 124(18), 1964\u20131972.","journal-title":"Circulation"},{"issue":"19","key":"1186_CR3","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2013.282437","volume":"310","author":"JA Barreto-Filho","year":"2013","unstructured":"Barreto-Filho, J. A., et al. (2013). Trends in aortic valve replacement for elderly patients in the United States, 1999\u20132011. JAMA, 310(19), 2078\u20132085.","journal-title":"JAMA"},{"issue":"6","key":"1186_CR4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/joim.12174","volume":"275","author":"M Martinez-Selles","year":"2014","unstructured":"Martinez-Selles, M., et al. (2014). Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. Journal of Internal Medicine, 275(6), 608\u2013620.","journal-title":"Journal of Internal Medicine"},{"issue":"9","key":"1186_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cjca.2014.03.005","volume":"30","author":"G Gadey","year":"2014","unstructured":"Gadey, G., & Reynolds, M. R. (2014). Cost-effectiveness considerations in transcatheter management of valvular heart disease. Canadian Journal of Cardiology, 30(9), 1058\u20131063.","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"1186_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.14797\/mdcj-8-2-26","volume":"8","author":"MJ Reardon","year":"2012","unstructured":"Reardon, M. J. (2012). Cost-effectiveness analysis of TAVR. Methodist DeBakey Cardiovascular Journal, 8(2), 26\u201328.","journal-title":"Methodist DeBakey Cardiovascular Journal"},{"issue":"4","key":"1186_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/S0266462300008461","volume":"5","author":"GW Torrance","year":"1989","unstructured":"Torrance, G. W., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5(4), 559\u2013575.","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"1186_CR8","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2005","unstructured":"Drummond, M. F., et al. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press."},{"issue":"2","key":"1186_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14737167.2.2.99","volume":"2","author":"GW Torrance","year":"2002","unstructured":"Torrance, G. W., Furlong, W., & Feeny, D. (2002). Health utility estimation. Expert Review of Pharmacoeconomics & Outcomes Research, 2(2), 99\u2013108.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"2","key":"1186_CR10","first-page":"207","volume":"29","author":"A Gafni","year":"1994","unstructured":"Gafni, A. (1994). The standard gamble method: what is being measured and how it is interpreted. Health Services Research, 29(2), 207\u2013224.","journal-title":"Health Services Research"},{"issue":"7","key":"1186_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005650-199607000-00004","volume":"34","author":"GW Torrance","year":"1996","unstructured":"Torrance, G. W., et al. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702\u2013722.","journal-title":"Medical Care"},{"issue":"2","key":"1186_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00019053-200017020-00004","volume":"17","author":"C Green","year":"2000","unstructured":"Green, C., Brazier, J., & Deverill, M. (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151\u2013165.","journal-title":"Pharmacoeconomics"},{"key":"1186_CR13","volume-title":"How to score version 2 of the SF-36 health survey: (standard & acute forms)","author":"JE Ware","year":"2000","unstructured":"Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 health survey: (standard & acute forms). Lincolm, RI: QualityMetric Inc."},{"issue":"3","key":"1186_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney, C. A., Ware, J. E, Jr, & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247\u2013263.","journal-title":"Medical Care"},{"issue":"4","key":"1186_CR15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0003-4975(02)03371-4","volume":"73","author":"PE Falcoz","year":"2002","unstructured":"Falcoz, P. E., et al. (2002). Comparison of the Nottingham Health Profile and the 36-item health survey questionnaires in cardiac surgery. Annals of Thoracic Surgery, 73(4), 1222\u20131228.","journal-title":"Annals of Thoracic Surgery"},{"issue":"6","key":"1186_CR16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00000658-199706000-00017","volume":"225","author":"EE Tseng","year":"1997","unstructured":"Tseng, E. E., et al. (1997). Aortic valve replacement in the elderly. Risk factors and long-term results. Annals of Surgery, 225(6), 793\u2013802. (discussion 802-4).","journal-title":"Annals of Surgery"},{"issue":"19 Suppl 3","key":"1186_CR17","first-page":"Iii70-4","volume":"102","author":"TM Sundt","year":"2000","unstructured":"Sundt, T. M., et al. (2000). Quality of life after aortic valve replacement at the age of >80\u00a0years. Circulation, 102(19 Suppl 3), Iii70-4.","journal-title":"Circulation"},{"issue":"4","key":"1186_CR18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/14034948980260040401","volume":"26","author":"JH Loge","year":"1998","unstructured":"Loge, J. H., & Kaasa, S. (1998). Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scandinavian Journal of Social Medicine, 26(4), 250\u2013258.","journal-title":"Scandinavian Journal of Social Medicine"},{"issue":"5","key":"1186_CR19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000333406","volume":"4","author":"TI Karlsen","year":"2011","unstructured":"Karlsen, T. I., et al. (2011). Validity of the SF-36 in patients with morbid obesity. Obesity Facts, 4(5), 346\u2013351.","journal-title":"Obesity Facts"},{"issue":"6","key":"1186_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpainsymman.2007.01.011","volume":"34","author":"OM Fredheim","year":"2007","unstructured":"Fredheim, O. M., et al. (2007). Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management, 34(6), 657\u2013665.","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"1186_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337\u2013343.","journal-title":"Annals of Medicine"},{"issue":"3","key":"1186_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. (1990). EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199\u2013208.","journal-title":"Health Policy"},{"issue":"3","key":"1186_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14737167.3.3.293","volume":"3","author":"J Brazier","year":"2003","unstructured":"Brazier, J., et al. (2003). Use of visual analog scales in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research, 3(3), 293\u2013302.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"4","key":"1186_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/02729890122062622","volume":"21","author":"GW Torrance","year":"2001","unstructured":"Torrance, G. W., Feeny, D., & Furlong, W. (2001). Visual analog scales: Do they have a role in the measurement of preferences for health states? Medical Decision Making, 21(4), 329\u2013334.","journal-title":"Medical Decision Making"},{"issue":"5","key":"1186_CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0895-4356(89)90136-4","volume":"42","author":"DG Froberg","year":"1989","unstructured":"Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences\u2014II: Scaling methods. Journal of Clinical Epidemiology, 42(5), 459\u2013471.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"1186_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","volume":"42","author":"C Herrmann","year":"1997","unstructured":"Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale\u2014A review of validation data and clinical results. Journal of Psychosomatic Research, 42(1), 17\u201341.","journal-title":"Journal of Psychosomatic Research"},{"key":"1186_CR27","volume-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","author":"New York Heart Association Criteria, C.","year":"1979","unstructured":"New York Heart Association Criteria, C. (1979). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston: Little, Brown."},{"issue":"12","key":"1186_CR28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang, R. M., et al. (2005). Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18(12), 1440\u20131463.","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"2","key":"1186_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","volume":"15","author":"MA Quinones","year":"2002","unstructured":"Quinones, M. A., et al. (2002). Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography, 15(2), 167\u2013184.","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"1","key":"1186_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","volume":"76","author":"JH Chesebro","year":"1987","unstructured":"Chesebro, J. H., et al. (1987). Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical Findings through hospital discharge. Circulation, 76(1), 142\u2013154.","journal-title":"Circulation"},{"issue":"5","key":"1186_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., et al. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373\u2013383.","journal-title":"Journal of Chronic Diseases"},{"issue":"11","key":"1186_CR32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., et al. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology, 47(11), 1245\u20131251.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"1186_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<41::AID-HEC395>3.0.CO;2-#","volume":"8","author":"J Brazier","year":"1999","unstructured":"Brazier, J., & Deverill, M. (1999). A checklist for judging preference-based measures of health related quality of life: Learning from psychometrics. Health Economics, 8(1), 41\u201351.","journal-title":"Health Economics"},{"issue":"2","key":"1186_CR34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N","volume":"5","author":"P Dolan","year":"1996","unstructured":"Dolan, P., et al. (1996). The time trade-off method: Results from a general population study. Health Economics, 5(2), 141\u2013154.","journal-title":"Health Economics"},{"key":"1186_CR35","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Laurence Erlbaum."},{"issue":"4","key":"1186_CR36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mhl.2002.124554","volume":"31","author":"JA Bennett","year":"2002","unstructured":"Bennett, J. A., et al. (2002). Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung: The Journal of Acute and Critical Care, 31(4), 262\u2013270.","journal-title":"Heart & Lung: The Journal of Acute and Critical Care"},{"issue":"9667","key":"1186_CR37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","volume":"373","author":"BA Carabello","year":"2009","unstructured":"Carabello, B. A., & Paulus, W. J. (2009). Aortic stenosis. Lancet, 373(9667), 956\u2013966.","journal-title":"Lancet"},{"key":"1186_CR38","doi-asserted-by":"crossref","DOI":"10.1007\/1-4020-5511-0","volume-title":"EQ-5D value sets: Inventory, comparative review and user guide","author":"A Szende","year":"2007","unstructured":"Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer Netherlands."},{"issue":"6737","key":"1186_CR39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/bmj.300.6737.1458","volume":"300","author":"ML Slevin","year":"1990","unstructured":"Slevin, M. L., et al. (1990). Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ, 300(6737), 1458\u20131460.","journal-title":"BMJ"},{"issue":"6","key":"1186_CR40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(87)90019-1","volume":"40","author":"GW Torrance","year":"1987","unstructured":"Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 40(6), 593\u2013603.","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"1186_CR41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0272989X9701700212","volume":"17","author":"H Bleichrodt","year":"1997","unstructured":"Bleichrodt, H., & Johannesson, M. (1997). An experimental test of a theoretical foundation for rating-scale valuations. Medical Decision Making, 17(2), 208\u2013216.","journal-title":"Medical Decision Making"},{"issue":"9","key":"1186_CR42","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.1995.13.9.2369","volume":"13","author":"J Donk van der","year":"1995","unstructured":"van der Donk, J., et al. (1995). Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: A comparison of state and process utilities. Journal of Clinical Oncology, 13(9), 2369\u20132378.","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"1186_CR43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00005650-199509000-00004","volume":"33","author":"MP Rutten-van Molken","year":"1995","unstructured":"Rutten-van Molken, M. P., et al. (1995). Methodological issues of patient utility measurement. Experience from two clinical trials. Medical Care, 33(9), 922\u2013937.","journal-title":"Medical Care"},{"issue":"2","key":"1186_CR44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1026446302100","volume":"6","author":"AE Clarke","year":"1997","unstructured":"Clarke, A. E., et al. (1997). The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Quality of Life Research, 6(2), 169\u2013184.","journal-title":"Quality of Life Research"},{"issue":"5","key":"1186_CR45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.1995.01690170063009","volume":"131","author":"KA Zug","year":"1995","unstructured":"Zug, K. A., et al. (1995). Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Archives of Dermatology, 131(5), 561\u2013568.","journal-title":"Archives of Dermatology"},{"issue":"23","key":"1186_CR46","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura, R. A., et al. (2014). 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), e521\u2013e643.","journal-title":"Circulation"},{"issue":"7","key":"1186_CR47","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1524-4733.2008.00394.x","volume":"11","author":"A Lloyd","year":"2008","unstructured":"Lloyd, A., et al. (2008). Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations. Value in Health, 11(7), 1178\u20131185.","journal-title":"Value in Health"},{"issue":"2\u20133","key":"1186_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.healthpol.2007.05.004","volume":"84","author":"P McNamee","year":"2007","unstructured":"McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy, 84(2\u20133), 321\u2013331.","journal-title":"Health Policy"},{"issue":"25","key":"1186_CR49","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2012.09.018","volume":"60","author":"MR Reynolds","year":"2012","unstructured":"Reynolds, M. R., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). Journal of the American College of Cardiology, 60(25), 2683\u20132692.","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"1186_CR50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2011-300444","volume":"98","author":"M Watt","year":"2012","unstructured":"Watt, M., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart, 98(5), 370\u2013376.","journal-title":"Heart"},{"issue":"5","key":"1186_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0272989X03258421","volume":"23","author":"LG Singer","year":"2003","unstructured":"Singer, L. G., Theodore, J., & Gould, M. K. (2003). Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Medical Decision Making, 23(5), 435\u2013440.","journal-title":"Medical Decision Making"},{"issue":"15","key":"1186_CR52","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1995.03520390045031","volume":"273","author":"RF Nease Jr","year":"1995","unstructured":"Nease, R. F, Jr, et al. (1995). Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA, 273(15), 1185\u20131190.","journal-title":"JAMA"},{"issue":"10","key":"1186_CR53","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0277-9536(96)00271-7","volume":"44","author":"P Dolan","year":"1997","unstructured":"Dolan, P., & Sutton, M. (1997). Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Social Science and Medicine, 44(10), 1519\u20131530.","journal-title":"Social Science and Medicine"},{"issue":"1","key":"1186_CR54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0272989X07312478","volume":"30","author":"JN Doctor","year":"2010","unstructured":"Doctor, J. N., Bleichrodt, H., & Lin, H. J. (2010). Health utility bias: A systematic review and meta-analytic evaluation. Medical Decision Making, 30(1), 58\u201367.","journal-title":"Medical Decision Making"},{"issue":"4481","key":"1186_CR55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.7455683","volume":"211","author":"A Tversky","year":"1981","unstructured":"Tversky, A., & Kahneman, D. (1981). The framing of decisions and the psychology of choice. Science, 211(4481), 453\u2013458.","journal-title":"Science"},{"issue":"1","key":"1186_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0895-4356(93)90011-O","volume":"46","author":"K Gerard","year":"1993","unstructured":"Gerard, K., Dobson, M., & Hall, J. (1993). Framing and labelling effects in health descriptions: Quality adjusted life years for treatment of breast cancer. Journal of Clinical Epidemiology, 46(1), 77\u201384.","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-015-1186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-015-1186-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-015-1186-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:58:43Z","timestamp":1718211523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-015-1186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s11136-015-1186-1","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"type":"print","value":"0962-9343"},{"type":"electronic","value":"1573-2649"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}